Opportunity Information: Apply for RFA CK 19 004
This grant opportunity, titled "Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD)," is a CDC funding announcement designed to keep an ongoing national public health study running. The study originally began in 1995 and focuses on a very specific question: whether classic forms of Creutzfeldt-Jakob Disease could be transmitted through blood transfusion. The work centers on identifying and following people who received blood products from donors who were later diagnosed with classic CJD, then assessing whether any evidence of transfusion-related transmission emerges over time. In plain terms, the CDC is supporting continued surveillance and follow-up so the country can better understand and quantify any transfusion-associated risk tied to classic CJD.
The funding is offered as a cooperative agreement, which typically means the CDC expects to have substantial involvement in the project rather than simply awarding funds and stepping back. The activity category is health, and the listing is under CFDA 93.084. The opportunity number is RFA CK 19 004, and it was posted by the Department of Health and Human Services, Centers for Disease Control and Prevention (CDC). The announcement was created on November 28, 2018, with an original application deadline of March 19, 2019. Applications needed to be submitted electronically by 5:00 p.m. Eastern Time on the due date.
In terms of scale, the award ceiling is $77,000, and the CDC anticipated making one award. That combination suggests a focused, single-site (or single-lead) continuation effort rather than a large multi-award research program. Eligibility is listed broadly as "Others" with additional eligibility details referenced in the full announcement, implying that the CDC expected proposals from a specialized entity capable of operating and maintaining this kind of long-running, nationwide tracking study. Overall, the opportunity is essentially a continuation award aimed at sustaining a long-established monitoring effort that informs blood safety policy and public health understanding of whether classic CJD poses a meaningful risk through blood products.Apply for RFA CK 19 004
- The Department of Health and Human Services, Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.084.
- This funding opportunity was created on Nov 28, 2018.
- Applicants must submit their applications by Mar 19, 2019 Electronically submitted applications must be submitted no later than 500 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $77,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
1. What is the title of this grant opportunity?
The opportunity is titled "Study to Assess the Risk of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob Disease (CJD)."
2. Who is offering this funding opportunity?
This is a funding announcement from the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC).
3. What is the purpose of the grant?
The purpose is to keep an ongoing national public health study running. The study is designed to assess whether classic forms of Creutzfeldt-Jakob Disease (CJD) could be transmitted through blood transfusion.
4. What specific public health question does the study address?
The study focuses on whether classic CJD may be transfusion-transmitted (passed through blood products) by tracking recipients of blood products from donors who were later diagnosed with classic CJD and observing whether evidence of transfusion-related transmission appears over time.
5. When did the underlying study begin?
The study originally began in 1995.
6. What activities does the project involve?
Based on the description provided, the work centers on identifying and following people who received blood products from donors later diagnosed with classic CJD, and then assessing whether any evidence of transfusion-related transmission emerges over time. This includes continued surveillance and follow-up.
7. Is this grant described as new research or a continuation effort?
The opportunity is essentially a continuation award intended to sustain a long-established, ongoing monitoring effort rather than launching a new large research program.
8. What type of funding mechanism is being used?
The CDC is offering the funding as a cooperative agreement.
9. What does it mean that this is a cooperative agreement?
As described, a cooperative agreement typically means the CDC expects to have substantial involvement in the project, rather than only providing funds and stepping back.
10. What is the activity category for this opportunity?
The activity category is health.
11. What is the CFDA listing for this opportunity?
The listing is under CFDA 93.084.
12. What is the opportunity number?
The opportunity number is RFA CK 19 004.
13. When was this announcement created?
The announcement was created on November 28, 2018.
14. What was the application deadline?
The original application deadline was March 19, 2019.
15. What time were applications due on the deadline date?
Applications needed to be submitted electronically by 5:00 p.m. Eastern Time on the due date.
16. How much funding is available under this opportunity?
The award ceiling is $77,000.
17. How many awards did the CDC anticipate making?
The CDC anticipated making one award.
18. What does the combination of a single anticipated award and a $77,000 ceiling suggest?
It suggests a focused, single-lead continuation effort rather than a large, multi-award research program.
19. Who is eligible to apply?
Eligibility is listed broadly as "Others," with additional eligibility details referenced in the full announcement.
20. Does the opportunity description indicate what kind of applicant the CDC expected?
Yes. Based on the summary provided, it implies the CDC expected proposals from a specialized entity capable of operating and maintaining a long-running, nationwide tracking and follow-up study of this type.
21. What is the main public health value of continuing this study?
The continuation supports surveillance and follow-up that help the country better understand and quantify any transfusion-associated risk tied to classic CJD, informing blood safety policy and broader public health understanding.
22. What disease and transmission pathway are the focus of the study?
The disease is classic forms of Creutzfeldt-Jakob Disease (CJD), and the transmission pathway under assessment is potential blood-borne transmission through blood transfusion (blood products).
23. What is meant by "blood products" in the context provided?
In the provided description, "blood products" refers to blood transfusion-related products received by individuals from donors who were later diagnosed with classic CJD.
24. Is the focus on classic CJD or other forms?
The opportunity description specifically focuses on classic forms of Creutzfeldt-Jakob Disease (CJD).
25. How were applications required to be submitted?
Applications needed to be submitted electronically.
Browse more opportunities from the same category: Health
Next opportunity: DOE SBIR/STTR FY2019 Phase I Release 2
Previous opportunity: Archives Collaboratives
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CK 19 004
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CK 19 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Quantifying Contact Rates and Mixing Patterns in Workers in Non-healthcare Work Settings in the United States and Modeling the Effect of Workplace Social Distancing Measures in Reducing Influenza Transmission Apply for RFA CK 19 002 Funding Number: RFA CK 19 002 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $350,000 |
| Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) Apply for RFA TS 19 001 Funding Number: RFA TS 19 001 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $500,000 |
| Rural Residency Planning and Development Program Apply for HRSA 19 088 Funding Number: HRSA 19 088 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Healthy Kids 2019 Apply for CMS 1Y1 19 001 Funding Number: CMS 1Y1 19 001 Agency: Department of Health and Human Services, Centers for Medicare Medicaid Services Category: Health Funding Amount: $1,500,000 |
| National Rural Health Policy, Community, and Collaboration Program Apply for HRSA 19 021 Funding Number: HRSA 19 021 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| National Center of Excellence for Infant and Early Childhood Mental Health Consultation Apply for SM 19 010 Funding Number: SM 19 010 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $1,000,000 |
| Grants for Expansion and Sustainability of the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances Apply for SM 19 009 Funding Number: SM 19 009 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $3,000,000 |
| Career Pathway to Independence in Blood Science Award for Physician Scientists (K99/R00 Independent Clinical Trial Required) Apply for RFA HL 20 002 Funding Number: RFA HL 20 002 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Career Pathway to Independence in Blood Science Award for Physician Scientists (K99/R00 Independent Clinical Trial Not Allowed) Apply for RFA HL 20 001 Funding Number: RFA HL 20 001 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| CDC's Collaboration with Academia to Strengthen Public Health Workforce Capacity Apply for CDC RFA OE17 17010201SUPP19 Funding Number: CDC RFA OE17 17010201SUPP19 Agency: Department of Health and Human Services, Centers for Disease Control - CSELS Category: Health Funding Amount: $130,000 |
| The Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet) Apply for RFA DD 19 002 Funding Number: RFA DD 19 002 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $375,000 |
| Improving Detection and Management of Glaucoma and Other Eye Diseases Among High Risk Populations Apply for RFA DP 19 004 Funding Number: RFA DP 19 004 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $700,000 |
| Research Approaches to Improve the Care and Outcomes of People Living with Spina Bifida Apply for RFA DD 19 001 Funding Number: RFA DD 19 001 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $800,000 |
| Occupational Safety and Health Surveillance Collaboration, Education and Translation Apply for RFA OH 19 002 Funding Number: RFA OH 19 002 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $225,000 |
| Advanced Nursing Education Nurse Practitioner Residency (ANE-NPR) Program Apply for HRSA 19 001 Funding Number: HRSA 19 001 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIDCR Mentoring Network to Support a Diverse Dental, Oral and Craniofacial Research Workforce (UE5 Clinical Trials Not Allowed) Apply for RFA DE 19 007 Funding Number: RFA DE 19 007 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $250,000 |
| U3D Maternal and Child Health Measurement Research Network (MRN) Apply for HRSA 19 071 Funding Number: HRSA 19 071 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $301,000 |
| Research Grants for Preventing Violence and Violence Related Injury (R01) Apply for RFA CE 19 005 Funding Number: RFA CE 19 005 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $350,000 |
| Etiologic and Effectiveness Research to Address Polysubstance Impaired Driving Apply for RFA CE 19 004 Funding Number: RFA CE 19 004 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $350,000 |
| Research to Enhance the US Vision and Eye Health Surveillance System Apply for RFA DP 19 005 Funding Number: RFA DP 19 005 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $850,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CK 19 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.